title: Leflunomide-associated tuberculosis?
authors.forename: A
authors.initials: A
authors.lastname: Hocevar
authors.forename: B
authors.initials: B
authors.lastname: Rozman
authors.forename: S
authors.initials: S
authors.lastname: Praprotnik
authors.forename: B
authors.initials: B
authors.lastname: Lestan
authors.forename: D
authors.initials: D
authors.lastname: Erzen
authors.forename: V
authors.initials: V
authors.lastname: Petric
authors.forename: M
authors.initials: M
authors.lastname: Tomsic
mesh_terms: D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007555:Isoxazoles / Q000009:adverse effects*; D000077339:Leflunomide; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced*; D014397:Tuberculosis, Pulmonary / Q000139:chemically induced*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide